Description
Denik Pharm EXENOXY 2 mg is a premium research formulation containing Exenatide, a synthetic Glucagon-Like Peptide-1 (GLP-1) receptor agonist developed for advanced investigations into metabolic physiology, glucose regulation, endocrine signaling, and energy homeostasis. Structurally inspired by exendin-4, a naturally occurring peptide, Exenatide has become an important research molecule for scientists studying the complex biological interactions that regulate insulin secretion, appetite signaling, and gastrointestinal hormone activity.
As one of the earliest and most extensively characterized GLP-1 receptor agonists, Exenatide has played a pivotal role in advancing metabolic research. Its well-defined pharmacological profile enables researchers to explore the molecular pathways involved in glucose metabolism, pancreatic β-cell function, gastric motility, and neuroendocrine communication, making it an invaluable tool in endocrine and metabolic biology.
Each package contains 5 lyophilized vials, with 2 mg of Exenatide per vial, providing researchers with a high-purity formulation suitable for precision laboratory investigations. Manufactured by Denik Pharm, EXENOXY is produced under stringent pharmaceutical-quality standards to ensure exceptional purity, stability, and batch-to-batch consistency.
Key Features
- Premium Exenatide research peptide
- 2 mg of high-purity peptide per vial
- 5 lyophilized vials per pack
- Synthetic GLP-1 receptor agonist derived from exendin-4
- High-purity laboratory-grade formulation
- Extensively researched in metabolic physiology and endocrine biology
- Suitable for investigations involving GLP-1 receptor signaling, glucose metabolism, pancreatic function, and appetite regulation
- Manufactured under rigorous pharmaceutical-quality standards
- Intended exclusively for laboratory and scientific research applications
How It Works
Exenatide selectively binds to GLP-1 receptors expressed in pancreatic tissue, the gastrointestinal tract, and the central nervous system. Activation of these receptors initiates intracellular signaling pathways that regulate glucose-dependent insulin secretion, glucagon modulation, gastric emptying, and metabolic communication.
In laboratory studies, EXENOXY is widely utilized to investigate GLP-1 receptor pharmacology, pancreatic β-cell signaling, appetite-related neuroendocrine pathways, and energy balance. Researchers also examine its effects on intracellular signaling mechanisms such as cAMP, Protein Kinase A (PKA), and related pathways involved in metabolic regulation, making Exenatide an important research compound in endocrinology, obesity research, and metabolic science.
This formulation is intended exclusively for laboratory and scientific research and is not intended for human consumption.
Contents
Active Ingredient: Exenatide – 2 mg
Packaging: 5 Lyophilized Vials




Reviews
There are no reviews yet.